Losartan potassium

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

423 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Hypertension	D006973	EFO_0000537	I10	16	23	59	56	28	177
Kidney diseases	D007674	EFO_0003086	N08	3	7	8	15	16	49
Essential hypertension	D000075222	—	I10	2	5	25	6	1	38
Diabetic nephropathies	D003928	EFO_0000401	—	1	4	3	7	7	21
Covid-19	D000086382	—	U07.1	1	7	7	3	1	17
Type 2 diabetes mellitus	D003924	EFO_0001360	E11	2	3	4	4	4	16
Diabetes mellitus	D003920	HP_0000819	E08-E13	1	2	3	7	3	16
Chronic renal insufficiency	D051436	—	N18	2	1	2	2	9	16
Syndrome	D013577	—	—	3	4	7	2	—	15
Proteinuria	D011507	HP_0000093	R80	—	2	3	4	6	15

Show 87 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Marfan syndrome	D008382	Orphanet_558	Q87.4	—	2	7	—	—	9
Arachnodactyly	D054119	—	—	—	2	7	—	—	9
Nephritis	D009393	—	N05	—	1	2	—	1	4
Non-alcoholic fatty liver disease	D065626	EFO_0003095	K75.81	—	3	1	—	—	4
Pulmonary fibrosis	D011658	—	J84.10	1	2	1	—	2	4
Hyperlipidemias	D006949	HP_0003077	E78.5	1	1	1	—	—	3
Pneumonia	D011014	EFO_0003106	—	—	1	1	—	—	2
Acute kidney injury	D058186	HP_0001919	N17	—	1	1	—	1	2
Glioblastoma	D005909	EFO_0000515	—	—	1	1	—	—	2
Cognitive dysfunction	D060825	HP_0001268	G31.84	—	2	1	—	—	2

Show 19 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Pancreatic neoplasms	D010190	EFO_0003860	C25	3	5	—	—	1	9
Cardiomyopathies	D009202	EFO_0000318	I42	1	3	—	—	2	5
Neoplasms	D009369	—	C80	2	2	—	—	—	4
Adenocarcinoma	D000230	—	—	3	1	—	—	—	4
Aging	D000375	GO_0007568	R41.81	1	2	—	—	2	4
Sickle cell anemia	D000755	EFO_0000697	D57	1	3	—	—	—	4
Breast neoplasms	D001943	EFO_0003869	C50	2	1	—	—	—	3
Morbid obesity	D009767	EFO_0001074	—	1	1	—	—	2	3
Cystic fibrosis	D003550	EFO_0000390	E84	1	2	—	—	—	3
Post-traumatic stress disorders	D013313	EFO_0001358	F43.1	—	1	—	—	2	3

Show 57 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Healthy volunteers/patients	—	—	—	23	—	—	—	8	31
Malnutrition	D044342	EFO_0008572	E40-E46	2	—	—	—	2	4
Recurrence	D012008	—	—	2	—	—	—	1	3
Drug interactions	D004347	—	—	3	—	—	—	—	3
Carcinoma	D002277	—	C80.0	2	—	—	—	—	2
Pure autonomic failure	D054970	—	—	2	—	—	—	—	2
Arteriovenous fistula	D001164	—	Q27.3	1	—	—	—	1	2
Fistula	D005402	—	—	1	—	—	—	1	2
Pre-eclampsia	D011225	EFO_0000668	O14	1	—	—	—	—	1
Osteosarcoma	D012516	—	—	1	—	—	—	—	1

Show 50 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Albuminuria	D000419	EFO_0004285	R80.9	—	—	—	—	2	2
Systolic heart failure	D054143	EFO_1001207	I50.20	—	—	—	—	1	1
Frailty	D000073496	—	R53.1	—	—	—	—	1	1
Urologic diseases	D014570	—	N39.9	—	—	—	—	1	1
Systemic scleroderma	D012595	EFO_0000717	M34	—	—	—	—	1	1
Localized scleroderma	D012594	EFO_1001361	L94.0	—	—	—	—	1	1
Diffuse scleroderma	D045743	EFO_0000404	—	—	—	—	—	1	1
Memory	D008568	—	—	—	—	—	—	1	1
Learning	D007858	—	—	—	—	—	—	1	1
Lupus nephritis	D008181	EFO_0005761	—	—	—	—	—	1	1